Office of Policy and Planning

Peter G. Lurie, M.D., M.P.H., Acting Associate Commissioner

Mission

The Office of Policy and Planning (OPP) provides strategic policy direction, planning, and data-driven analysis for the Food and Drug Administration (FDA) to more effectively and efficiently protect and promote the public health. 

OPP does this by:

• developing significant and cross-cutting policy and engaging in strategic problem solving;
• serving as FDA’s focal point for the development, coordination, oversight, and processing of regulations, guidances and other policy documents;
• conducting economic analyses, program evaluations, and special studies;  
• leading overall FDA strategic, performance, and business process planning, including the development of outcome measures; and

Major Functions

• Advises the Commissioner and other key agency officials on matters relating to agency policy, regulations development, legislative issues, risk communication, and planning and evaluation activities.
• Provides strategic policy direction, planning, and data-driven analysis for FDA to more effectively and efficiently protect and promote public health.
• Develops significant and cross-cutting policy and engages in strategic problem solving.
• Serves as FDA’s focal point for the development, coordination, oversight, and processing of regulations, guidance and other policy documents.
• Conducts economic analyses, program evaluations, and special studies.
• Leads overall FDA strategic, performance and business process planning, including the development of performance measures
• Leads and coordinates agency-wide efforts to plan, evaluate and improve FDA risk communication.

Contact the Office of Policy and Planning

Acting Associate Commissioner: Peter G. Lurie, M.D., M.P.H.
Phone: 301-796-4800 | Fax: 301-847-8616 | Email: peter.lurie@fda.hhs.gov

White Oak Office:
Food and Drug Administration
Office of Policy and Planning
Building 32, 10903 New Hampshire Avenue, Silver Spring, MD 20993